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Review Article
Current Strategies in Prevention of
Postoperative Infections in Spine Surgery
Kivanc Atesok, MD, MSc1,2 , Efstathios Papavassiliou, MD2,
Michael J. Heffernan, MD3, Danny Tunmire, RN, BSN, CNOR, CRNFA1,
Irina Sitnikov, RN, MN4, Nobuhiro Tanaka, MD, PhD5,
Sakthivel Rajaram, MD1, Jason Pittman, MD, PhD1,
Ziya L. Gokaslan, MD6,7, Alexander Vaccaro, MD, PhD8,
and Steven Theiss, MD1
Abstract
Study Design: Narrative review.
Objectives: Postoperative surgical site infections (SSIs) are among the most common acute complications in spine surgery and
have a devastating impact on outcomes. They can lead to increased morbidity and mortality as well as greater economic burden.
Hence, preventive strategies to reduce the rate of SSIs after spine surgery have become vitally important. The purpose of this article
was to summarize and critically analyze the available evidence related to current strategies in the prevention of SSIs after spine surgery.
Methods: A literature search utilizing Medline database was performed. Relevant studies from all the evidence levels have been
included. Recommendations to decrease the risk of SSIs have been provided based on the results from studies with the highest
level of evidence.
Results: SSI prevention occurs at each phase of care including the preoperative, intraoperative, and postoperative periods.
Meticulous patient selection, tight glycemic control in diabetics, smoking cessation, and screening/eradication of Staphylococcus
aureus are some of the main preoperative patient-related preventive strategies. Currently used intraoperative measures include
alcohol-based skin preparation, topical vancomycin powder, and betadine irrigation of the surgical site before closure. Post-
operative infection prophylaxis can be performed by administration of silver-impregnated or vacuum dressings, extended
intravenous antibiotics, and supplemental oxygen therapy.
Conclusions: Although preventive strategies are already in use aloneor in combination, further high-level research is required to prove
their efficacy in reducing the rate of SSIs in spine surgery before evidence-based standard infection prophylaxis guidelines can be built.
Keywords
spine surgery, surgical site infection, prevention
Introduction
Surgical site infection (SSI) following spine surgery is a relatively
common complication and has a devastating impact on outcomes.
The reported incidence of deep SSIs after spine surgery ranges
from 1% to 4%.1,2 Previous evidence indicates that postoperative
infections are recognized as one of the most common complica-
tions causing hospital readmission following spine surgery.3,4
The effects of SSIs after spine procedures on patient out-
comes and the cost of care can be dismal. This drastic compli-
cation may result in prolonged hospitalization, long-term
intravenous (IV) antibiotic treatment, reoperations, work-day
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loss, permanent disability, or mortality.5-13 Calderone et al6
reported a more than 4 times increase in the total cost of care
as result of the additional expenses involved in treating patients
with deep SSI after lower back fusion. Petilon et al10 showed
that patients who suffered postoperative SSI after instrumented
lumbar spinal fusion had significantly worse back pain scores
(P ¼ .02) compared with patients who did not have postopera-
tive infection. Moreover, a significantly smaller proportion of
patients in the infection group (27%) achieved the minimum
clinically important difference on the Oswestry Disability
Index when compared with the patients in the no-infection
group (60%; P ¼ .018). Casper et al13 found significantly
higher mortality rates in patients with postoperative spinal
infections compared with a matched control group at 1 year
(4.62% vs 1.2%; P ¼ .006), 2 years (7.73% vs 2.25%; P ¼
.001), and 5 years (15.45% vs 3.43%; P ¼ .0002).
Preventive strategies to reduce the rate of SSIs after spine
surgery have become critically important due to the deleterious
impacts of this complication on patients and health care sys-
tems. These strategies can be separated into 3 main categories:
preoperative optimization of patient-related risk factors, intrao-
perative, and postoperative measures to prevent SSIs.
Preoperative Optimization of Patient-
Related Risk Factors
Demographic Variables, Patient Selection, and
Comorbidity Assessment
Patient-related risk factors for SSI after spine surgery have
been well described in the literature, with suggestions for mod-
ification of individual factors.2,14 However, patient selection
considering age, sex, nutritional status, and comorbidities as
a whole, along with the risks associated with the planned spinal
procedure, can aid in reducing the incidence of preventable
catastrophic outcomes. Although older age has not been shown
to be an independent risk factor for SSIs,15 studies indicate that
the mean age of patients who develop SSIs after spine surgery
tends to be higher,16,17 and patients older than the mid-50s can
have a significantly higher risk for developing SSI.18,19 Simi-
larly, gender has not been shown to be one of the predictors of
SSIs in various studies15,17; however, there is sporadic evi-
dence that female sex is an independent risk factor.20
Obesity with body mass index (BMI) above 30 kg/m2 and
diabetes mellitus (DM) are among the important patient-related
factors that have been shown to be associated with an increased
risk of SSIs.17,20 Although obesity is an independent risk factor
for SSIs, poor nutritional status and low albumin or recent
weight loss may also affect body’s immune defense mechan-
isms negatively and predispose patients to SSIs after spine
surgery.20,21 In a retrospective comparative study by Wang
et al,22 the mean serum albumin was significantly lower in
patients who developed SSIs after posterior lumbar spinal pro-
cedures compared with those who had similar surgeries but did
not develop SSIs (36.9 vs 43.2, respectively; P < .0001). It is
advisable to approach patients with serum albumin below
35 g/L as “high risk for SSI” and improve their nutritional
status before spinal procedures.
DM, congestive heart failure (CHF), steroid use, smoking,
alcohol abuse, and anemia (adult hematocrit < 35) have all been
revealed as important risk factors for SSIs after spine surgery
by different researchers.17,19,20,23 In a study including 1532
surgical spine patients whose demographic, comorbidity, and
complication data was collected prospectively, Lee et al23
showed that the odds of an SSI in patients with a history of
CHF were 3.07 times greater than the odds for those without
CHF (95% confidence interval [CI]: 1.33-7.06; P ¼ .008).
Those with a history of DM had a 2.09 odds of having SSI
(95% CI: 1.08-4.06; P ¼ .03). Fang et al19 reviewed 1095
patients who underwent spinal procedures. Data from 48
patients who developed postoperative SSIs was compared with
data from a randomly selected group of 95 uninfected patients.
Smoking and alcohol abuse were found to be significant pre-
dictors for postoperative SSI (P ¼ .03 and P ¼ .04, respec-
tively). Lieber et al20 reviewed 1110 patients with SSIs
following spinal surgery and showed that hematocrit less than
35 and preoperative steroid use of more than 10 days were
significant risk factors for development of SSIs. In a prospec-
tive multicenter surveillance and risk factor analysis, Ogihara
et al24 showed that preoperative oral steroid therapy is an inde-
pendent risk factor for the development of deep SSIs after
posterior thoracolumbar spinal surgeries. Patients with preo-
perative oral steroid therapy had an 8.53 times higher risk for
developing deep SSIs compared with patients without steroid
therapy (95% CI: 2.49-25.82; P ¼ .001).
Currently, there is a paucity of literature reporting the
effects of immunodeficiencies and other chronic diseases, such
as liver or kidney failure, on postoperative spinal infection
rates. However, it is would be reasonable to expect an increased
SSI risk in such patients.
In the pediatric age group, several studies report an
increased SSI risk in patients with underlying medical condi-
tions such as spina bifida, cerebral palsy, Marfan syndrome,
muscular dystrophy, and the presence of ventriculoperitoneal
shunt.25-27 Paralleling these reports, SSI rates for healthy chil-
dren with idiopathic spine disorders range between 1% and 3%,
whereas up to 17% of spine operations involving children with
neuromuscular disease are complicated by SSIs.28,29
It is also important to note that previous spine surgery has
been described as one of the independent and unmodifiable risk
factors for SSI. Healing of a surgical wound results in scar
tissue formation that contains mainly fibroblasts and non-
randomly aligned collagen fibers with inferior functional and
structural quality compared to normal tissue. Therefore, spine
surgeons have to meet the challenges of working through pre-
viously damaged soft tissues in revision surgeries. In a retro-
spective study, Kurtz et al30 showed that the overall incidence
of SSIs in adult patients after instrumented lumbar fusion was
12.2% in revisions and 8.5% in primary procedures with an
adjusted hazard ratio of 1.66 (95% CI: 1.28-2.15; P < .001).
Likewise, Warner et al31 reported that the incidence of deep
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SSIs in pediatric patients following spinal fusion was 8.3% in
revisions and 3.3% in primary surgeries (P ¼ .057).
Risk Categorization
There is evidence supporting the premise that comorbidities are
associated with an increased risk of SSIs both in the adult and
pediatric populations.15-23 However, there are no risk categor-
ization systems to help surgeons determine which patients need
to be approached as high risk for SSI after spine procedures
based on their comorbidities. The authors propose including the
patients with key independent risk factors in high-risk category
for developing SSI after spine surgery (Table 1).
Optimization of Modifiable Risk factors
Smoking Cessation. Smoking is one of the modifiable risk factors
that significantly increases the risk of SSIs after spinal sur-
gery.32 Smoking has been shown to have a detrimental effect
on tissue oxygenation, which impairs the reparative processes
of wound healing and the neutrophil defense against patho-
genic microorganisms.33-38 In a randomized controlled trial
with 78 healthy subjects who were exposed to a standard inci-
sional wound near the sacrum, Sorensen et al39 demonstrated
that the wound infection rate in smokers was 12%, compared
with 2% in those who had never smoked (P < .05). Wound
infections were significantly fewer in abstinent smokers com-
pared with continuous smokers after 4, 8, and 12 weeks. Hence,
smoking cessation at least 4 weeks before surgery is critically
important to decreasing the risk of infection in spine patients.
Preoperative Glycemic Management.High blood glucose has been
shown to impair blood B lymphocyte function40 and attenuate
the angiogenic capability of endothelial cells, which would
eventually decrease tissues’ healing potential.41 There is fur-
ther evidence that directly links hyperglycemia to postopera-
tive SSIs such as inhibition of keratinocyte and fibroblast
migration, inhibition of wound healing, and increased biofilm
formation by microorganisms such as Staphylococcus aureus
and Staphylococcus epidermidis in a concentration-dependent
manner.42,43 Hence, tight glycemic control may decrease the
risk of postoperative SSIs by minimizing the negative effects of
hyperglycemia on immune status and the healing capacity of
the surgical wounds. Cancienne et al44 reported that patients
who underwent single-level lumbar decompression with peri-
operative hemoglobin (Hb) A1C level of 7.5% or above had a
significantly higher risk for deep infection compared with
patients below this threshold (odds ratio: 2.9; 95% CI: 1.8-
4.9; P < .0001). Hikata et al45 investigated 345 patients who
underwent posterior instrumented thoracic and lumbar spinal
arthrodesis. In this series, of the 36 patients with DM, 16.7%
developed postoperative SSI. Among the 309 patients without
DM, only 3.2% developed SSI (P ¼ .0005). Although the peri-
operative serum glucose level did not differ between DM
patients who did and those who did not develop SSI, the peri-
operative HbA1C value was significantly higher in diabetic
patients who developed SSI (7.6% vs 6.9%, P ¼ .006). Based
on available evidence, it could be suggested that HbA1C level
should be lowered below 7.0% preoperatively to minimize the
risk of SSIs in spine patients with DM.
Screening and Eradication of S aureus. Staphylococcus aureus is
recognized as the most commonly encountered microorganism
in patients with SSIs after spine surgery. The pooled average
contribution of S aureus infections to spinal SSIs was calcu-
lated to be as high as 49.3%.9 There are 2 important reasons
why S aureus is the most commonly isolated pathogen in
patients with SSIs. First, it is a part of normal flora of the body,
frequently found in the nose, respiratory tract, and on the skin.
Second, S aureus has many virulence factors that make this
microorganism capable of causing infections. These virulence
factors include surface proteins that promote attachment to host
proteins or formation of biofilms and the ability to secrete
proteins, toxins, and enzymes to protect itself from the host’s
immune response and to convert the host tissue into nutrients
required for bacterial growth. Kim et al46 studied 7019 patients
who underwent preoperative screening using nasal swabs for S
aureus before elective orthopedic surgeries, including arthro-
plasty, spine surgery, and sports medicine procedures. The
patients who tested positive for S aureus were managed with
intranasal 2% mupirocin ointment twice daily for 5 days and a
shower wash with 2% chlorhexidine once daily for 5 days. In
their series, the percentages of the patients who were found to
be carriers for methicillin-sensitive and methicillin-resistant S
aureus (MSSA and MRSA) were 22.6% and 4.4%, respec-
tively. A significantly higher rate of SSI was observed among
MRSA carriers compared with noncarriers (0.97% vs 0.14%, P
¼ .0162). The rate of SSI among MSSA carriers (0.19%) was
also higher than that of noncarriers (P ¼ .709). The screening
and treatment program was associated with an overall 59%
reduction in the rate of SSIs compared with that during the
period preceding the start of the screening program. In a pro-
spective observational study, Rao et al47 reported similar
results with significantly lower SSIs (P¼ .016) in patients who
were screened and treated for S aureus colonization compared
with the control group.




Chronic liver disease or CHF
Steroid use
Smoking
Anemia with hematocrit <35
Obesity (BMI > 30 kg/m2)
Low serum albumin <35 g/L
Neuromuscular disordersa
Revision surgeries
Abbreviations: SSI, surgical site infection; DM, diabetes mellitus; CHF, conges-
tive heart failure; BMI, body mass index.
aDiagnosis of neuromuscular disorders increases the risk of SSIs in pediatric
age group.
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Based on current evidence, it is justifiable to suggest routine
preoperative S aureus screening with nasal swabs, as well as
eradication using mupirocin ointment and chlorhexidine baths,
before spinal procedures.
Preoperative Antiseptic Showers and Antiseptic Dressings. Chlor-
hexidine is an antiseptic that dissociates and releases positively
charged chlorhexidine cation at physiologic pH. The binding of
this cationic molecule to negatively charged bacterial cell walls
results in bactericidal effects via disruption of the bacterial cell
wall and membrane. Edmiston et al48 demonstrated that a stan-
dardized preadmission shower regimen that includes 118mL of
aqueous chlorhexidine gluconate (CHG) 4% per shower, a min-
imum of 2 sequential showers, and a 1-minute pause before
rinsing results in maximal skin surface concentrations of CHG
that are sufficient to inhibit or kill Gram-positive or Gram-
negative surgical wound pathogens. However, meta-analysis
of prospective controlled trials suggested no significant benefit
of whole-body preoperative bathing with CHG for prevention
of SSIs.49,50 Most studies included in these meta-analysis
reports omitted the details of CHG concentrations or applica-
tion protocols.49,50
As an alternative to CHG showers, CHG no-rinse cloth
application to the surgical site (the night before and morning
of surgery) has been suggested as an effective method of pre-
venting SSIs in orthopedic surgical patients.51,52 These reports
compared the addition of CHG no-rinse cloth protocols with
standard in-hospital skin preparation only that consisted of
antiseptic painting of the surgical site following induction of
anesthesia and positioning of the patient on the operating table.
Hence, current evidence does not support any superiority of
CHG dressings over CHG showers in the prevention of SSIs.
Intraoperative Preventive Measures
Intravenous Antibiotics
Intraoperative IV antibiotic prophylaxis has been proven to be
a safe and efficacious means of reducing the risk of SSIs after
spine surgery.53,54 Although the superiority of one antibiotic
agent or dosing regimen over another has not been clearly
demonstrated,53 administration of a broad-spectrum antibiotic
covering S aureus, such as cefazolin, 30 minutes before skin
incision with redosing every 4 hours during longer surgeries,
has become common practice in spine surgery.14 Evidence
suggests that skeletal muscle concentration of cefazolin peaks
within 30 to 60 minutes after the first IV dose.55 Hence, it
seems reasonable to initiate parenteral prophylaxis with cefa-
zolin within 1 hour before skin incision. In patients who are
allergic to penicillin or cefazolin, clindamycin can be used as a
safe alternative. To further investigate the association between
the prophylaxis timing and the occurrence of SSIs, Steinberg
et al56 studied 109 patients with SSIs. When antibiotics requir-
ing long infusion rates (vancomycin and fluoroquinolones)
were excluded, the infection risk following administration of
antibiotic within 30 minutes prior to incision was 1.6%,
compared with an infection risk of 2.4% associated with
administration 31 to 60 minutes prior to incision (OR: 1.74;
95% CI: 0.98-3.04). Intraoperative redosing also appeared to
reduce SSI risk in operations lasting longer than 4 hours (OR of
3.08 with no redosing; 95% CI: 0.74-12.90). Further studies
with large patient numbers are needed to support the conclu-
sions of Steinberg et al.56
Another point worth discussing is whether the duration of IV
antibiotic administration should be extended until the drain is
removed in patients after spinal procedures. It has been shown
that wound drains can be colonized with pathogenic microor-
ganisms, and retrograde migration of skin flora along the drain
is common.57 Wound drains are often left in place for over 24
hours due to the likelihood of high output for an extended
period of time following spinal surgery. In practice, it is com-
mon for spine surgeons to continue IV antibiotics as long as the
drain is in place postoperatively. However, in a prospective
randomized study, Takemoto et al58 showed that continuing
perioperative administration of antibiotics for the entire time
a drain is in place after spinal surgery did not decrease the rate
of SSIs. Hence, we recommend limiting the use of periopera-
tive antibiotic prophylaxis to 24 hours and avoiding the use of
broader spectrum antimicrobials unless there are clear indica-
tions of a need to prevent resistance development.
Skin Preparation
Intraoperative skin preparation before the surgical incision is
the standard of care in any transcutaneous surgical procedure
that aims to minimize direct inoculation of the wound with the
skin flora.59 The most commonly used solutions for intraopera-
tive skin antisepsis include CHG and povidone-iodine with or
without isopropyl alcohol. Darouiche et al60 compared the effi-
cacy of CHG-alcohol scrub with povidone-iodine (no alcohol)
in a prospective randomized trial including 849 patients under-
going clean-contaminated surgery (ie, colorectal, small intest-
inal, gastroesophageal, biliary, thoracic, gynecologic, or
urologic operations). The overall rate of SSI was significantly
lower in the CHG-alcohol group than in the povidone-iodine
group (9.5% vs 16.1%, respectively; P ¼ .004). Savage et al61
compared CHG-alcohol (Chloraprep—2% chlorhexidine glu-
conate and 70% isopropyl alcohol; Enturia, El Paso, Texas)
with iodine-alcohol (Duraprep—0.7% available iodine and
74% isopropyl alcohol; 3M Healthcare, St Paul, Minnesota)
in a prospective randomized study including 100 patients
undergoing elective lumbar spine surgery. There was no dif-
ference in the rate of positive skin culture between the CHG-
alcohol and iodine-alcohol groups (0/50 vs 3/50, respectively;
P ¼ .24) after skin preparation and after wound closure (17/50
vs 16/50, respectively; P ¼ .22). Based on these studies, it can
be speculated that combining CHG or povidone-iodine with
alcohol offers better skin antisepsis than using either solution
without the addition of alcohol. A previously published
meta-analysis did not find sufficient high-level evidence to
recommend the combined application of CHG-alcohol and
povidone-iodine-alcohol over the use of these solutions in
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isolation.62 However, in a randomized controlled trial includ-
ing 407 patients undergoing elective spine surgery, Patrick
et al63 showed significantly lower viable bacteria after skin
disinfection with sequential application of povidone-iodine-
alcohol and CHG-alcohol compared with application of only
povidone-iodine-alcohol twice. It should be noted that the
study demonstrated bacterial viability as the outcome measure
and the clinical implications of positive culture results in terms
of risk for SSIs remain to be studied.
Wound Irrigation
SSIs typically result from contamination of the surgical site
during the interval between the skin incision and wound clo-
sure.64 Savage et al61 demonstrated a significant increase in
positive culture results taken from the surgical site after wound
closure compared with the rate following skin preparation
(33% vs 3%, respectively; P < .0001). Hence, intraoperative
irrigation of the surgical site before wound closure is believed
to be effective in the prevention of bacterial colonization and
may reduce the risk of SSIs (Figure 1). Nevertheless, evidence
to date is not sufficient to establish consensus and suggest
guidelines regarding surgical wound irrigation practices in
spine surgery. In a retrospective series of 223 patients after
spine surgery, Watanabe et al15 reported 14 SSIs. Mean saline
irrigation over 2000 mL/h showed a strong association with the
prevention of SSI (OR: 0.08).
Povidone-iodine (PVP-I) is an antiseptic solution composed
of polyvinylpyrrolidone (povidone, PVP) and elemental iodine.
Iodine molecules released from PVP-I penetrate and destroy
the cell wall of microorganisms, and they impair vital events
such as protein synthesis by forming complexes with amino
acids and unsaturated fatty acids. Chang et al65 investigated
the use of PVP-I solution for wound irrigation in a series with
244 patients undergoing primary posterior lumbosacral instru-
mented fusion. The wound irrigation in the study group (N ¼
120) was performed with 0.35% PVP-I followed by normal
saline solution, and in the control group (N¼ 124) with normal
saline only. The infection rate was significantly lower in the
study group, with no difference in fusion rate, wound healing,
or clinical outcomes. In a prospective randomized trial with
414 patients undergoing spinal procedures including
decompression, discectomy, tumor excision, and pedicle screw
fixation, Cheng et al66 used 0.35% PVP-I in 208 patients.
The infection rate was significantly lower in the PVP-I group
(P ¼ .0072). Despite these encouraging results, concerns exist
regarding potential negative effects of PVP-I on tissues at
the cellular level. In vitro and animal studies indicate cytotoxic
effects of PVP-I (at 0.35% or lower concentrations) on
osteoblasts and neuronal tissues.67,68 Therefore, wound irriga-
tion with PVP-I solutions needs to be studied further before
recommendations for or against its use in spine surgery can be
justified.
Theoretically, CHG can be considered an alternative to sal-
ine or PVP-I for intraoperative wound irrigation,69 but current
literature does not provide any evidence regarding the use of
CHG wound irrigation in spine surgery.
Intrawound Vancomycin Powder
The application of local vancomycin in powder form within the
surgical wound as an adjunct to parenteral antibiotics to
decrease the risk of SSI has gained widespread popularity
among spine surgeons (Figure 2). Intrawound vancomycin
powder appears to be a promising option for additional anti-
biotic prophylaxis due to its low cost, extensive availability,
ease of application, good safety profile, and perception of
effectiveness.70
Vancomycin inhibits the synthesis of the peptidoglycan
layer in the bacterial cell wall and causes the bacteria to lyse.
Vancomycin is very effective against most commonly isolated
pathogens in SSIs such as Gram-positive rods and cocci,
including MRSA and multidrug-resistant S epidermidis.71 Due
to its poor oral bioavailability, vancomycin is administered
intravenously and distributed to the tissues through the sys-
temic circulation. However, the distribution of any IV antibio-
tics in a surgical wound can be limited by factors such as
hematoma and soft tissue damage around the wound, obesity,
and diabetes.72 Thus, intrawound application of vancomycin
can help in achieving minimum inhibitory concentrations
(MIC) for common microorganisms in a surgical wound for
Figure 1. Image from a long thoracic posterior spinal instrumentation
and fusion case. Wound irrigation using 3 liters of normal saline was
performed before closure. (Courtesy of Danny Tunmire, RN, BSN,
CNOR, CRNFA, University of Alabama at Birmingham, Department
of Orthopaedic Surgery, Birmingham, AL, USA.)
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an extended period of time without exposing other tissues to
potentially toxic effects of IV administration. Armaghani
et al73 measured daily postoperative vancomycin levels in
serum and drain outputs in pediatric patients after spinal defor-
mity correction. All patients received prophylactic IV cefazolin
perioperatively and 1 gram of vancomycin powder applied
into the surgical wound before closure. The mean serum van-
comycin levels were 2.5 mg/mL, 1.9 mg/mL, and 1.1 mg/mL on
postoperative day 0 (POD 0: immediately after the operation),
POD 1, and POD 2, respectively. The mean vancomycin levels
in drain output were 403 mg/mL, 251 mg/mL, and 115 mg/mL on
POD 0, 1, and 2, respectively. Intrawound application of van-
comycin powder produced local levels well above the MIC for
common wound pathogens (2-4 mg/mL) and serum levels
below the toxicity threshold (25 mg/mL).
There is growing evidence suggesting that intrawound
application of vancomycin powder may be effective in decreas-
ing the risk for SSIs after spinal surgery.74-77 Strom et al74
reported that the rate of infection after posterior cervical fusion
fell from 10.9% to 2.5% (P¼ .0384) following the introduction
of vancomycin powder. In a multicenter prospective study with
2056 patients, Devin et al76 demonstrated that the risk of
SSI was higher in patients in whom intrawound vancomycin
powder was not used (P < .001). Khan et al77 performed a
meta-analysis of spinal SSI and vancomycin powder including
9 retrospective cohort studies and 1 randomized controlled
trial. There were 2574 cases and 106 infections (4.1%) in the
control group, in which vancomycin powder was not used, and
2518 cases and 33 infections (1.3%) in the treatment group, in
which the patients received intrawound vancomycin (absolute
risk reduction ¼ 2.8%). The patients who had instrumented
spinal operations had a reduced risk of SSI with vancomycin
powder (P ¼ .023) compared with those who had noninstru-
mented spinal operations (P ¼ .226). It is plausible to expect
that the reduction in the incidence of SSIs after spine surgery
associated with intrawound application of vancomycin
powder would also reduce the infection-related costs.78,79
Godil et al79 reported that the use of intrawound vancomycin
powder can lead to cost savings of $438 165 per 100 spinal
fusions performed.
Contrary to many prior studies, some retrospective reports
with a limited number of patients did not show a significant
reduction in SSI risk with vancomycin powder.80,81 Further-
more, concerns regarding potentially negative in vitro effects
of vancomycin powder on dural cells or osteoblasts82,83 have
not been supported by in vivo animal experiments or clinical
studies.16,84
Another point worth mentioning is the potential impact of
widespread use of intrawound vancomycin on creating
vancomycin-resistant organisms or microbial selection.
Although development of vancomycin-resistant pathogens is
a reasonable concern, evidence to date does not show an
increase in SSIs caused by such pathogens in patients who
received intrawound vancomycin.85 Chotai et al85 studied
2802 patients of whom 1215 received intrawound vancomycin
powder during index spine surgery while the rest did not
receive it. There was a significantly lower rate of deep SSIs
in the vancomycin powder group compared with the control
group (1.6% vs 2.5%, P ¼ .02). None of the patients who had
intrawound vancomycin and subsequently developed S aureus
SSI demonstrated pathogens with resistance to vancomycin.
Grabel et al86 reported 115 SSIs after 5909 elective spinal
procedures. Intrawound vancomycin powder was used in 42
and not used in 73 of the infected cases. The culture results
revealed 23.8% polymicrobial and 16.7% Gram-negative
growth in the vancomycin group compared with 9.6% (P ¼
.039) and 4.1% (P¼ .021) in the no-vancomycin group, respec-
tively. Although this study showed a higher prevalence of poly-
microbial and Gram-negative culture results in patients that
ultimately developed postoperative SSIs, there was no suffi-
cient data in terms of patient comorbidities such as diabetes
that might be a predisposing factor for Gram-negative or poly-
microbial SSIs. For this reason, spine surgeons occasionally
prefer applying intrawound vancomycin along with tazocin
powder to cover both Gram-positive and Gram-negative
microorganisms.
Figure 2. Images from a posterior spinal instrumentation and fusion between the level of cervical two to six with laminectomies from cervical
three to five. (A) Two vials of vancomycin (500 mg per vial) were opened. (B) One gram of vancomycin powder was applied throughout the
hardware bilaterally.
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Based on high level evidence regarding the safety and effec-
tiveness of intrawound vancomycin, we suggest routine appli-
cation of vancomycin powder both in adult (1 g) and pediatric
(0.5 g) patients undergoing instrumented posterior spinal pro-
cedures to decrease the risk of spinal SSIs. We note that the
literature does not include any reports to suggest an alternative
intrawound antibiotic for patients who are allergic to vancomy-
cin. However, there is evidence supporting the local use of
daptomycin-loaded polymethylmethacrylate beads in patients
with periprosthetic joint infections, and prosthetic vascular
graft infections.87,88 Hence, it can be speculated that dapto-
mycin powder will emerge in the near future as an alternative
intrawound antibiotic for patients who are allergic to
vancomycin.
Intraoperative Oxygenation and Body Temperature
Regulation
Tissue perfusion and oxygenation are vitally important deter-
minants of tissue viability, resistance to infection, and wound
healing after surgery. Hence, in addition to adequate perfusion
to the surgical wound, the fraction of inspired oxygen (FiO2)
administered intraoperatively has been suggested as a modifi-
able risk factor for SSI after spinal surgery.89 In a case-control
study, Maragakis et al89 found that 68% of the patients with
SSIs after spinal procedures received less than 50% FiO2
intraoperatively compared with 34% of the patients who did
not develop SSIs. The authors suggested that FiO2 less than
50% is an independent, modifiable risk factor for SSI after
spinal surgery. Supporting these findings for intraoperative
oxygenation, Inanmaz et al90 underlined the importance of tis-
sue oxygenation during the postoperative period in a study
including 42 patients after neuromuscular scoliosis surgery.
The infection rate in patients who received hyperbaric oxygen
therapy (5 sessions/week for 6 weeks) was lower compared
with those who did not receive such therapy (5.5% vs
16.6%). Interestingly, in a retrospective study including
4498 patients, Wanta et al91 compared 1250 patients with
SSIs with 3248 control patients who did not develop SSIs
after vascular, general, orthopedic, neurologic, and spine sur-
geries. The authors could not demonstrate any decrease in
SSIs with increased intraoperative FiO2. Furthermore, higher
intraoperative FiO2 exposure was associated with higher odds
of SSI in the neurological and spine populations. These
authors speculated that unfavorable consequences of hyper-
oxia such as free radical–induced cellular damage and apop-
tosis might have mitigated any benefit of increased tissue
oxygenation in clean wounds. Therefore, keeping in mind that
the normal FiO2 in air is 21%, it may be advisable not to
increase the FiO2 to levels far beyond 50% in patients under-
going surgeries under general anesthesia.
The biological and physiologic cascades in the human body
are optimized for a narrow temperature range around 36.5C to
37.5C. Because the use of general anesthesia inhibits the body’s
thermoregulatory responses, perioperative hypothermia is not an
uncommon condition for patients undergoing lengthy spinal
surgeries. Hypothermia increases total oxygen consumption,
induces coagulopathy, and alters the functions of the immune
system.92 As a result, hypothermia may increase the risk of SSIs
after spine surgery. There is evidence in favor of perioperative
active warming to decrease the risk of SSIs.93,94 Tsuchida et al95
showed that severe (<35C) and late-nadir (<36C occurring
after 2 hours of anesthesia induction) hypothermia were associ-
ated with a greater incidence of SSIs after prolonged gastroen-
terological surgery. In a case-control study, Brown et al96 could
not demonstrate a significant association between intraoperative
hypothermia and SSIs in patients with clean surgical wounds.
The main limitations of this study were retrospective data gath-
ering and lack of homogeneity in the complexity of the surgical
procedures between the groups.
Based on current evidence, it would be most reasonable to
suggest keeping the FiO2 at 50% and the body temperature




The antibacterial activity of silver against both Gram-positive
and Gram-negative pathogens has long been known and has
found a variety of applications because its toxicity to human
cells is considerably lower than to bacteria.97,98 Although the
exact mechanisms by which silver exerts its antimicrobial
effects are yet to be fully elucidated, proposed mechanisms
of action include alteration of the bacterial cell wall and/or cell
membrane structure, inhibition of DNA replication and respira-
tory activity with modification of intracellular ATP levels.98
Silver-impregnated wound dressings containing slow-release
silver ions have been used to decrease the risk of wound
infections after surgery (Figure 3).99 Epstein et al99 compared
silver-impregnated dressing with regular dressing (iodine- or
alcohol-based swab and dry 4  4 gauze) in patients under-
going lumbar laminectomies with instrumented fusion. There
were 11 superficial and 3 deep wound infections in the regular
dressing group. None of the patients in the silver dressing group
developed superficial or deep wound infections. In a meta-
analysis of 9 randomized controlled trials with a total of
2196 patients (1141 patients in the silver-containing-dressing
group vs 1055 patients in the control group), Li et al100 found
that silver-containing dressing was not associated with lower
incidence of SSI after colorectal surgery, vascular surgery,
fracture surgery, or caesarian delivery.
Although current evidence is not conclusive, the routine use
of silver-impregnated wound dressings after posterior spine
surgery is commonly practiced in many health centers across
North America.
Closed Incision Negative-Pressure Wound Therapy
The use of closed incision negative-pressure (CI-NPWT) has
been advocated by researchers because this therapy has a
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positive impact on wound healing by diminishing the tensile
forces and edema, enhancing the removal of exudate, and
increasing the blood and lymphatic flow around the wound.101
In a retrospective case-control study including 160 patients
undergoing long-segment thoracolumbar spine fusions, Adogwa
et al102 compared the group that received CI-NPWT (N ¼ 46)
with controls who did not receive CI-NPWT (N ¼ 114). There
was a 50% decrease in the incidence of wound dehiscence in the
CI-NPWT group compared with controls (6.38% vs 12.28%,
respectively; P ¼ .02). The incidence of postoperative SSIs was
significantly lower in the CI-NPWT group compared with the
control group (10.63% vs 14.91%, respectively; P ¼ .04). Liu
et al103 investigated the effects of CI-NPWT in a meta-analysis
including 1295 patients from 5 randomized, quasi-randomized,
and controlled clinical studies who underwent lumbar spinal
surgeries. Although more patients in the control group con-
tracted postoperative fever than did those in the CI-NPWT
group, there was no significant difference between the 2 groups
in terms of the incidence of wound infection.
Current evidence does not include sufficient high-level evi-
dence defining the specific indications for using CI-NPWT
routinely in spine patients. Even so, it has been adapted by
many spine surgeons as a safe and effective means of wound
management in patients with increased risk of SSIs after spinal
procedures.
Dressing Change
Despite tremendous advances in sterile and surgical techniques
for reducing the risk of SSIs in spine surgery, there are no
guidelines or consensus regarding the ideal timing of dressing
change postoperatively. There are differences between institu-
tions and even among spine surgeons from the same institution
on how to manage the dressing after spine surgery. In general,
dressing change is performed after 2 days postoperatively.
Nevertheless, it has also been advocated that the sterile dres-
sings applied in the operating room after spinal surgeries may
serve as a barrier to bacterial inoculation and reduce the risk of
SSIs. Bains et al104 reported a decrease in the incidence of SSIs
after the institutional adoption of a new “dressing change”
protocol. Over a 15-year period, a total of 8631 instrumented
spine fusions were performed. There were 2473 cases per-
formed during the preprotocol period (1999-2004), during
which the dressing change was performed mostly on postopera-
tive day 2. The number of cases performed after the adoption of
the new “no dressing change for 5 days after surgery” protocol
was 6158 (2005-2013). Overall, after adoption of the new
dressing-change protocol, the incidence of SSIs decreased from
3.9% (97/2473) to 0.93% (57/6158) (P < .0001). The authors
suggested that “dressing changes in the immediate postopera-
tive period are not necessary” and that leaving the original
postoperative surgical dressing in place for 5 days may lead
to decreased SSIs. It must be noted that the study was per-
formed retrospectively and that the improvement in steriliza-
tion techniques and infection prevention measures during the
last decade might have confounded the results.
Although scientific evidence that supports the adoption of
new dressing change protocols after spine surgery is lacking, it
is reasonable not to open a sterile surgical wound to be exposed
to nosocomial pathogens during the immediate postoperative
period unless the dressing is soaked with blood or serosangui-
nous discharge.
Summary and Recommendations From
the Authors
SSIs after spine surgeries may severely affect clinical outcomes
and be an economic burden for the health care systems. Evi-
dence to date indicates several potential independent risk fac-
tors that may increase the likelihood of postoperative SSIs,
including obesity, DM, smoking, alcohol abuse, steroid use,
Figure 3. Demonstrates application of silver-impregnated pad after
wound closure.
Table 2. Summary of the Currently Used Strategies for Prevention of
























Abbreviations: SSI, surgical site infection; CHG-ETOH, chlorhexidine gluco-
nate–alcohol; CI-NPWT, closed incision negative pressure wound therapy.
aThere is supportive evidence for the use of these strategies in instrumented
posterior spinal procedures.
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neuromuscular disorders, anemia (adult hematocrit < 35),
S aureus colonization, and chronic diseases such as liver failure
or CHF. Current strategies for preventing postoperative infec-
tions in spine surgery can be summarized under 3 categories:
preoperative, intraoperative, and postoperative preventive
measures. In addition to routinely used preventive measures,
it is advisable to consider additional precautions based on
patient and procedure characteristics as well as independent
risk factors (Table 2).
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